Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib.

Li J, Zhang B, Zhang Y, Xu F, Zhang Z, Shao L, Yan C, Ulivi P, Denis MG, Christopoulos P, Thomas de Montpréville V, Bernicker EH, van der Wekken AJ, Wang C, Yue D

Open source

DOI: 10.21037/tlcr-21-160
Published: 2021 Mar
Container: Translational lung cancer research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/tlcr-21-160,
  title = {Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib.},
  author = {Li J and Zhang B and Zhang Y and Xu F and Zhang Z and Shao L and Yan C and Ulivi P and Denis MG and Christopoulos P and Thomas de Montpréville V and Bernicker EH and van der Wekken AJ and Wang C and Yue D},
  year = {2021},
  journal = {Translational lung cancer research},
  doi = {10.21037/tlcr-21-160},
  url = {https://doi.org/10.21037/tlcr-21-160}
}

RIS

TY  - JOUR
TI  - Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib.
AU  - Li J
AU  - Zhang B
AU  - Zhang Y
AU  - Xu F
AU  - Zhang Z
AU  - Shao L
AU  - Yan C
AU  - Ulivi P
AU  - Denis MG
AU  - Christopoulos P
AU  - Thomas de Montpréville V
AU  - Bernicker EH
AU  - van der Wekken AJ
AU  - Wang C
AU  - Yue D
PY  - 2021
JO  - Translational lung cancer research
DO  - 10.21037/tlcr-21-160
UR  - https://doi.org/10.21037/tlcr-21-160
ER  -

APA

J, L., B, Z., Y, Z., F, X., Z, Z., L, S., C, Y., P, U., MG, D., P, C., V, T. D. M., EH, B., AJ, V. D. W., C, W., & D, Y. (2021). Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib.. Translational lung cancer research. https://doi.org/10.21037/tlcr-21-160

Source records

pubmed · retrieved 2026-09-26T03:22:34.365Z